Insulet | PODD - تكلفة المبيعات





تكلفة المبيعات تغيير تاريخ
Abbott USD 5.94B 642M 2026-06
Align Technology USD 303.5M 60.47M 2026-03
AtriCure USD 34.98M 3.04M 2026-06
Avanos Medical USD 88M 6.9M 2026-03
Baxter International USD 1.81B 587M 2026-03
Becton, Dickinson and Co. USD 2.56B 281M 2026-03
Boston Scientific USD 1.83B 8M 2026-03
Cardinal Health USD 58.54B 4.82B 2026-03
Cooper Companies USD 393.8M 17M 2026-03
Dexcom USD 441.6M 25.3M 2026-03
Edwards Lifesciences USD 392.4M 29.8M 2026-06
Eli Lilly USD 3.58B 205M 2026-03
Globus Medical USD 263.59M 26.88M 2026-03
ICU Medical USD 337.72M 1.61M 2025-12
Inogen USD 39.59M 1.27M 2024-09
Insulet USD 232.7M 17.5M 2026-03
Integra LifeSciences USD 178.71M 14.73M 2026-03
J&J USD 8B 67M 2026-06
Medtronic USD 3.8B 195M 2026-03
Merit Medical Systems USD 197.08M 1.5M 2026-03
Roche Holding CHF 7.85B 630M 2026-06
Solventum Corp USD 911M 60M 2026-03
Stryker USD 2.36B 325M 2026-03
Tandem Diabetes Care USD 122.92M 7.96M 2025-12
Teleflex USD 240.84M 20.7M 2026-03
West Pharmaceutical Services USD 543.1M 5.4M 2026-06
Zimmer Biomet Holdings USD 738.3M 231.8M 2026-03